About
J3 Bioscience develops the LivRing®, a patented intravaginal delivery platform for sustained, controlled release of active ingredients, providing localized or systemic therapies designed specifically for women's health.
Explore J3 Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.